ArticleDermatology and therapy2023

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors.

Lana Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.